| A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants LG Fritsche, W Igl, JNC Bailey, F Grassmann, S Sengupta, ... Nature genetics 48 (2), 134-143, 2016 | 1404 | 2016 |
| Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema C Haritoglou, D Kook, A Neubauer, A Wolf, S Priglinger, R Strauss, ... Retina 26 (9), 999-1005, 2006 | 684 | 2006 |
| Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial M Schumacher, D Schmidt, B Jurklies, C Gall, I Wanke, C Schmoor, ... Ophthalmology 117 (7), 1367-1375. e1, 2010 | 317 | 2010 |
| Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two … CC Wykoff, F Abreu, AP Adamis, K Basu, DA Eichenbaum, Z Haskova, ... The Lancet 399 (10326), 741-755, 2022 | 248 | 2022 |
| Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema D Kook, A Wolf, T Kreutzer, A Neubauer, R Strauss, M Ulbig, A Kampik, ... Retina 28 (8), 1053-1060, 2008 | 245 | 2008 |
| The protective effect of quercetin against oxidative stress in the human RPE in vitro D Kook, AH Wolf, LY Alice, AS Neubauer, SG Priglinger, A Kampik, ... Investigative ophthalmology & visual science 49 (4), 1712-1720, 2008 | 177 | 2008 |
| Cardiovascular risk factors in central retinal artery occlusion: results of a prospective and standardized medical examination J Callizo, N Feltgen, S Pantenburg, A Wolf, AS Neubauer, B Jurklies, ... Ophthalmology 122 (9), 1881-1888, 2015 | 158 | 2015 |
| Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial SG Priglinger, AH Wolf, TC Kreutzer, D Kook, A Hofer, RW Strauss, ... Retina 27 (8), 1004-1012, 2007 | 154 | 2007 |
| Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion TC Kreutzer, CS Alge, AH Wolf, D Kook, J Burger, R Strauß, C Kunze, ... British Journal of Ophthalmology 92 (3), 351-355, 2008 | 135 | 2008 |
| Efficacy and safety of intravitreal gene therapy for Leber hereditary optic neuropathy treated within 6 months of disease onset NJ Newman, P Yu-Wai-Man, V Carelli, ML Moster, V Biousse, ... Ophthalmology 128 (5), 649-660, 2021 | 128 | 2021 |
| Epiretinal membrane characteristics correlate with photoreceptor layer defects in lamellar macular holes and macular pseudoholes RG Schumann, D Compera, MM Schaumberger, A Wolf, C Fazekas, ... Retina 35 (4), 727-735, 2015 | 105 | 2015 |
| Lamellar hole–associated epiretinal proliferation in comparison to epiretinal membranes of macular pseudoholes D Compera, E Entchev, C Haritoglou, R Scheler, WJ Mayer, A Wolf, ... American journal of ophthalmology 160 (2), 373-384. e1, 2015 | 101 | 2015 |
| Efficacy of treatment with ranibizumab in patients with wet age-related macular degeneration in routine clinical care: data from the COMPASS health services research A Wolf, A Kampik Graefe's Archive for Clinical and Experimental Ophthalmology 252, 647-655, 2014 | 99 | 2014 |
| Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusion WJ Mayer, A Wolf, M Kernt, D Kook, A Kampik, M Ulbig, C Haritoglou Eye 27 (7), 816-822, 2013 | 90 | 2013 |
| Risk- and non-risk-associated variants at the 10q26 AMD locus influence ARMS2 mRNA expression but exclude pathogenic effects due to protein deficiency U Friedrich, CA Myers, LG Fritsche, A Milenkovich, A Wolf, JC Corbo, ... Human molecular genetics 20 (7), 1387-1399, 2011 | 89 | 2011 |
| Oxidative stress-mediated induction of MMP-1 and MMP-3 in human RPE cells CS Alge-Priglinger, T Kreutzer, K Obholzer, A Wolf, M Mempel, M Kernt, ... Investigative ophthalmology & visual science 50 (11), 5495-5503, 2009 | 88 | 2009 |
| Clinical efficacy and safety of ranibizumab versus dexamethasone for central retinal vein occlusion (COMRADE C): a European label study H Hoerauf, N Feltgen, C Weiss, EM Paulus, S Schmitz-Valckenberg, ... American journal of ophthalmology 169, 258-267, 2016 | 86 | 2016 |
| Navigated macular laser decreases retreatment rate for diabetic macular edema: a comparison with conventional macular laser AS Neubauer, J Langer, R Liegl, C Haritoglou, A Wolf, I Kozak, ... Clinical Ophthalmology, 121-128, 2013 | 73 | 2013 |
| Spironolactone in the treatment of central serous chorioretinopathy–a case series TR Herold, K Prause, A Wolf, WJ Mayer, MW Ulbig Graefe's Archive for Clinical and Experimental Ophthalmology 252, 1985-1991, 2014 | 72 | 2014 |
| Secondary intraocular lens implantation: a large retrospective analysis E Vounotrypidis, I Schuster, MJ Mackert, D Kook, S Priglinger, A Wolf Graefe's Archive for Clinical and Experimental Ophthalmology 257, 125-134, 2019 | 67 | 2019 |
